Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated:  12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center / Harborview Medical Center
mi
from
Seattle, WA
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center / Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigational Site
mi
from
Orange, CA
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Saginaw, MI
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Saginaw, MI
Click here to add this to my saved trials
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Lincoln, NE
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lincoln, NE
Click here to add this to my saved trials
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Cleveland, OH
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Wynnewood, PA
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Falls Church, VA
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Falls Church, VA
Click here to add this to my saved trials
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Be'er Sheva,
Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
A Two-part, Randomized, Double-blind, Placebo-controlled, Single Dose Study of BCT197 for the Prevention of Acute Kidney Injury (AKI) in Patients Undergoing Elective Cardiac Surgery With Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Be'er Sheva,
Click here to add this to my saved trials
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Deland
mi
from
Deland, FL
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Deland
mi
from
Deland, FL
Click here to add this to my saved trials
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated:  12/31/1969
Banner University Medical Center
mi
from
Tucson, AZ
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated: 12/31/1969
Banner University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated:  12/31/1969
Lee Memorial Hospital
mi
from
Fort Myers, FL
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated: 12/31/1969
Lee Memorial Hospital
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated:  12/31/1969
St Lucie Medical Center
mi
from
Port Saint Lucie, FL
Emergency Treatment of Coral Snake Envenomation With Antivenom
Emergency Treatment of Coral Snake Envenomation With Antivenom
Status: Enrolling
Updated: 12/31/1969
St Lucie Medical Center
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Status: Enrolling
Updated:  12/31/1969
Arizona Emergency Medicine Research Center
mi
from
Phoenix, AZ
The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Status: Enrolling
Updated: 12/31/1969
Arizona Emergency Medicine Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Stress-induced Drinking in Emerging Adults: the Role of Trauma History
Stress-induced Drinking in Emerging Adults: the Role of Trauma History
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Stress-induced Drinking in Emerging Adults: the Role of Trauma History
Stress-induced Drinking in Emerging Adults: the Role of Trauma History
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Broward Research Group
mi
from
Hollywood, FL
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Broward Research Group
mi
from
Hollywood, FL
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Miami Research Associates
mi
from
South Miami, FL
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Kentucky Pediatric/ Adult Research
mi
from
Bardstown, KY
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Kentucky Pediatric/ Adult Research
mi
from
Bardstown, KY
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
SNBL Clinical Pharmacology Center
mi
from
Baltimore, MD
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
SNBL Clinical Pharmacology Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Buffalo Clinical Research Center, LLC
mi
from
Buffalo, NY
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Buffalo Clinical Research Center, LLC
mi
from
Buffalo, NY
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
PMG Research of Raleigh, LLC d/b/a PMG Research of Cary
mi
from
Cary, NC
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
PMG Research of Raleigh, LLC d/b/a PMG Research of Cary
mi
from
Cary, NC
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Volunteer Research Group
mi
from
Knoxville, TN
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Volunteer Research Group
mi
from
Knoxville, TN
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Benchmark Research
mi
from
Austin, TX
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Benchmark Research
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Roberta Braun, M.D.
mi
from
Austin, TX
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Roberta Braun, M.D.
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated:  12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1/2 Placebo-controlled, Randomized, Double-blind Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of 3 Ascending Dose Levels Of A 4-antigen Staphylococcus Aureus Vaccine (sa4ag) In Healthy Adults Aged 18 To <65 Years
Status: Enrolling
Updated: 12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
The Energy Dose Study
Comparative Effectiveness of Energy Doses in Critical Illness
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
The Energy Dose Study
Comparative Effectiveness of Energy Doses in Critical Illness
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Livestock Contact and MRSA in Rural Areas
Epidemiology of Rural MRSA : Is Livestock Contact a Risk Factor?
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Coralville, IA
Livestock Contact and MRSA in Rural Areas
Epidemiology of Rural MRSA : Is Livestock Contact a Risk Factor?
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Coralville, IA
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve-Metrohealth
mi
from
Cleveland, OH
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve-Metrohealth
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Brown University
mi
from
Providence, RI
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Univ of Texas Galveston
mi
from
Galveston, TX
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Univ of Texas Galveston
mi
from
Galveston, TX
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Utah Medical Center
mi
from
Salt Lake City, UT
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Utah Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
Randomized Controlled Study of Dipeptidyl Peptidase-4 (DPP4) Inhibitor (Sitagliptin) Therapy in the Inpatient Management of Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
Randomized Controlled Study of Dipeptidyl Peptidase-4 (DPP4) Inhibitor (Sitagliptin) Therapy in the Inpatient Management of Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials